Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2025-12-24 @ 3:45 PM
NCT ID:
NCT03946592
Brief Summary:
Evaluate the efficacy and safety of DWJ211 in patient with moderate or severe submental fat
Detailed Description:
DWJ211 is a injectable drug for improvement in the appearance of moderate to severe submental fat (SMF)
Study:
NCT03946592
Study Brief:
Protocol Section:
NCT03946592